Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine in DMARDs-refractory Rheumatoid Arthritis
NCT04535427Phase 2Unknown
- Sponsor
- Renji Hospital
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arginine in rheumatoid arthritis (RA), sponsored by Renji Hospital. Status: unknown.
02
Drugs
arginine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04535427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04535427.